Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis

Sang Won Lee, Min Chan Park, Yong Beom Park, Soo Kon Lee

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

We investigated whether serum leptin levels are elevated in patients with active rheumatoid arthritis (RA) and whether these levels correlate with disease activity. Fifty RA patients were enrolled in this study, and their disease activity was assessed using the disease activity score 28 (DAS28). The patients were divided into two groups according to this score: a high activity group with DAS28 > 3.2 (n = 26) and a low activity group with DAS28 >3.2 (n = 24). Serum leptin levels were determined using a primate antibody radioimmunoassay. RA patients with high disease activity had significantly higher mean serum leptin levels, compared to those with low activity (14.2 ± 10.9 vs. 7.0 ± 3.4 ng/ml, P < 0.05). Mean leptin levels adjusted according to BMI were 0.6 ± 0.5 ng m2/ml kg for the high activity group and 0.3 ± 0.2 ng m2/ml kg for the low activity group, respectively, which were also significantly different (P < 0.05). Both serum leptin levels and leptin levels adjusted according to BMI correlated well with the DAS28 (r = 0.363 and 0.368, P < 0.05) and CRP levels (r = 0.433 and 0.472, P < 0.05), respectively. Sixteen of the 26 RA patients with high disease activity at the initial assessment were re-evaluated, at which point their DAS28 had decreased to less than 3.2. Mean follow-up leptin level was significantly lower than mean initial leptin level (7.8 ± 3.7 vs. 16.1 ± 12.7 ng/ml, P < 0.05). In conclusion, serum leptin levels were higher in RA patients with high disease activity, correlated well with disease activity, and decreased significantly when disease was well controlled.

Original languageEnglish
Pages (from-to)537-540
Number of pages4
JournalRheumatology International
Volume27
Issue number6
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

Leptin
Rheumatoid Arthritis
Serum
Primates
Radioimmunoassay

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

@article{521e1db636f14442ae39e07fc3f7998a,
title = "Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis",
abstract = "We investigated whether serum leptin levels are elevated in patients with active rheumatoid arthritis (RA) and whether these levels correlate with disease activity. Fifty RA patients were enrolled in this study, and their disease activity was assessed using the disease activity score 28 (DAS28). The patients were divided into two groups according to this score: a high activity group with DAS28 > 3.2 (n = 26) and a low activity group with DAS28 >3.2 (n = 24). Serum leptin levels were determined using a primate antibody radioimmunoassay. RA patients with high disease activity had significantly higher mean serum leptin levels, compared to those with low activity (14.2 ± 10.9 vs. 7.0 ± 3.4 ng/ml, P < 0.05). Mean leptin levels adjusted according to BMI were 0.6 ± 0.5 ng m2/ml kg for the high activity group and 0.3 ± 0.2 ng m2/ml kg for the low activity group, respectively, which were also significantly different (P < 0.05). Both serum leptin levels and leptin levels adjusted according to BMI correlated well with the DAS28 (r = 0.363 and 0.368, P < 0.05) and CRP levels (r = 0.433 and 0.472, P < 0.05), respectively. Sixteen of the 26 RA patients with high disease activity at the initial assessment were re-evaluated, at which point their DAS28 had decreased to less than 3.2. Mean follow-up leptin level was significantly lower than mean initial leptin level (7.8 ± 3.7 vs. 16.1 ± 12.7 ng/ml, P < 0.05). In conclusion, serum leptin levels were higher in RA patients with high disease activity, correlated well with disease activity, and decreased significantly when disease was well controlled.",
author = "Lee, {Sang Won} and Park, {Min Chan} and Park, {Yong Beom} and Lee, {Soo Kon}",
year = "2007",
month = "4",
day = "1",
doi = "10.1007/s00296-006-0253-x",
language = "English",
volume = "27",
pages = "537--540",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "6",

}

Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. / Lee, Sang Won; Park, Min Chan; Park, Yong Beom; Lee, Soo Kon.

In: Rheumatology International, Vol. 27, No. 6, 01.04.2007, p. 537-540.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis

AU - Lee, Sang Won

AU - Park, Min Chan

AU - Park, Yong Beom

AU - Lee, Soo Kon

PY - 2007/4/1

Y1 - 2007/4/1

N2 - We investigated whether serum leptin levels are elevated in patients with active rheumatoid arthritis (RA) and whether these levels correlate with disease activity. Fifty RA patients were enrolled in this study, and their disease activity was assessed using the disease activity score 28 (DAS28). The patients were divided into two groups according to this score: a high activity group with DAS28 > 3.2 (n = 26) and a low activity group with DAS28 >3.2 (n = 24). Serum leptin levels were determined using a primate antibody radioimmunoassay. RA patients with high disease activity had significantly higher mean serum leptin levels, compared to those with low activity (14.2 ± 10.9 vs. 7.0 ± 3.4 ng/ml, P < 0.05). Mean leptin levels adjusted according to BMI were 0.6 ± 0.5 ng m2/ml kg for the high activity group and 0.3 ± 0.2 ng m2/ml kg for the low activity group, respectively, which were also significantly different (P < 0.05). Both serum leptin levels and leptin levels adjusted according to BMI correlated well with the DAS28 (r = 0.363 and 0.368, P < 0.05) and CRP levels (r = 0.433 and 0.472, P < 0.05), respectively. Sixteen of the 26 RA patients with high disease activity at the initial assessment were re-evaluated, at which point their DAS28 had decreased to less than 3.2. Mean follow-up leptin level was significantly lower than mean initial leptin level (7.8 ± 3.7 vs. 16.1 ± 12.7 ng/ml, P < 0.05). In conclusion, serum leptin levels were higher in RA patients with high disease activity, correlated well with disease activity, and decreased significantly when disease was well controlled.

AB - We investigated whether serum leptin levels are elevated in patients with active rheumatoid arthritis (RA) and whether these levels correlate with disease activity. Fifty RA patients were enrolled in this study, and their disease activity was assessed using the disease activity score 28 (DAS28). The patients were divided into two groups according to this score: a high activity group with DAS28 > 3.2 (n = 26) and a low activity group with DAS28 >3.2 (n = 24). Serum leptin levels were determined using a primate antibody radioimmunoassay. RA patients with high disease activity had significantly higher mean serum leptin levels, compared to those with low activity (14.2 ± 10.9 vs. 7.0 ± 3.4 ng/ml, P < 0.05). Mean leptin levels adjusted according to BMI were 0.6 ± 0.5 ng m2/ml kg for the high activity group and 0.3 ± 0.2 ng m2/ml kg for the low activity group, respectively, which were also significantly different (P < 0.05). Both serum leptin levels and leptin levels adjusted according to BMI correlated well with the DAS28 (r = 0.363 and 0.368, P < 0.05) and CRP levels (r = 0.433 and 0.472, P < 0.05), respectively. Sixteen of the 26 RA patients with high disease activity at the initial assessment were re-evaluated, at which point their DAS28 had decreased to less than 3.2. Mean follow-up leptin level was significantly lower than mean initial leptin level (7.8 ± 3.7 vs. 16.1 ± 12.7 ng/ml, P < 0.05). In conclusion, serum leptin levels were higher in RA patients with high disease activity, correlated well with disease activity, and decreased significantly when disease was well controlled.

UR - http://www.scopus.com/inward/record.url?scp=33947137320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947137320&partnerID=8YFLogxK

U2 - 10.1007/s00296-006-0253-x

DO - 10.1007/s00296-006-0253-x

M3 - Article

C2 - 17102946

AN - SCOPUS:33947137320

VL - 27

SP - 537

EP - 540

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 6

ER -